Sixty-six patients ( 25 females ; 6810 years ) undergoing elective aortic valve replacement surgery , with or without coronary artery bypass graft surgery , were randomized to the use of the CardioGard ( CardioGard Medical , Or-Yehuda , Israel ) Emboli Protection cannula ( `` treatment '' ) or a standard ( `` control '' ) aortic cannula .